By Dr Carl Andrew Power

Journal articles

Chen W; Tumanov S; Kong SMY; Cheng D; Michaëlsson E; Bongers A; Power C; Ayer A; Stocker R, 2022, 'Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque', Redox Biology, 58, http://dx.doi.org/10.1016/j.redox.2022.102532

Chandrakanthan V; Rorimpandey P; Zanini F; Chacon D; Olivier J; Joshi S; Kang YC; Knezevic K; Huang Y; Qiao Q; Oliver RA; Unnikrishnan A; Carter DR; Lee B; Brownlee C; Power C; Brink R; Mendez-Ferrer S; Enikolopov G; Walsh W; Göttgens B; Taoudi S; Beck D; Pimanda JE, 2022, 'Mesoderm-derived PDGFRA⁺ cells regulate the emergence of hematopoietic stem cells in the dorsal aorta', Nature Cell Biology, 24, pp. 1211 - 1225, http://dx.doi.org/10.1038/s41556-022-00955-3

Mattner F; Katsifis A; Bourdier T; Loc'h C; Berghofer P; Fookes C; Hung TT; Jackson T; Henderson D; Pham T; Lee BJ; Shepherd R; Greguric I; Wyatt N; Le T; Poon J; Power C; Fulham M, 2021, 'Synthesis and pharmacological evaluation of [¹⁸F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971', RSC Medicinal Chemistry, 12, pp. 1207 - 1221, http://dx.doi.org/10.1039/d1md00035g

Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Srivastava P; Potas JR; Hung T; Power C; Hardy P; Ma DD; Kilian KA; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE; Subramanian S, 2021, 'Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine', Science Advances, 7, pp. eabd1929, http://dx.doi.org/10.1126/sciadv.abd1929

Quinn CM; Porwal M; Meagher NS; Hettiaratchi A; Power C; Jonnaggadala J; McCullough S; Macmillan S; Tang K; Liauw W; Goldstein D; Zeps N; Crowe PJ; Jonnagaddala J, 2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10, http://dx.doi.org/10.1177/11772719211005745

Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Hung T; Power C; Hardy P; D D; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE; Chacon Fajardo D, 2021, 'Induction of Muscle Regenerative Multipotent Stem Cells from Human Adipocytes by PDGF-AB and 5-Azacytidine', Science Advances, pp. 2020.06.04.130872 - 2020.06.04.130872, http://dx.doi.org/10.1126/sciadv.abd1929

Chandrakanthan V; Rorimpandey P; Zanini F; Chacon D; Kang YC; Knezevic K; Huang Y; Qiao Q; Oliver R; Unnikrishnan A; Carter D; Lee B; Brownlee C; Power C; Mendez-Ferrer S; Enikolopov G; Walsh W; Göttgens B; Taoudi S; Beck D; Pimanda J, 2021, 'Mesoderm-Derived PDGFRA⁺Cells Regulate the Emergence of Hematopoietic Stem Cells in the Dorsal Aorta', , http://dx.doi.org/10.1101/2021.08.08.455592

Rashid I; Maghzal GJ; Chen YC; Cheng D; Talib J; Newington D; Ren M; Vajandar SK; Searle A; Maluenda A; Lindstedt EL; Jabbour A; Kettle AJ; Bongers A; Power C; Michaëlsson E; Peter K; Stocker R, 2018, 'Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque', European Heart Journal, 39, pp. 3301 - 3310, http://dx.doi.org/10.1093/eurheartj/ehy419

Menon J; Hoeppner VH; Judd A; Power CA; Bretscher PA, 2018, 'A hypothesis for the existence of two types of tuberculosis, reflecting two distinct types of immune failure to control the pathogen, based upon prevalence of mycobacterium-specific IgG subclasses', Scandinavian Journal of Immunology, 87, http://dx.doi.org/10.1111/sji.12665

Chandrakanthan V; Qiao Q; Kang YC; Knezevic K; Oliver R; Loo C; Anande G; Lee B; Walsh W; Power C; Wong J; Pimanda J, 2017, 'DECLINED PRESENTATION CHARACTERISATION OF STROMAL CELL POPULATIONS IN THE FOETAL LIVER AND THEIR CONTRIBUTIONS TO EMBRYONIC HAEMATOPOIETIC AND VASCULAR DEVELOPMENT', EXPERIMENTAL HEMATOLOGY, 53, pp. S118 - S118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000972742900273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Norddin N; Power C; Watson G; Cowin G; Kurniawan ND; Gluch L; Bourne RM, 2015, 'Microscopic diffusion properties of fixed breast tissue: Preliminary findings', Magnetic Resonance in Medicine, 74, pp. 1733 - 1739, http://dx.doi.org/10.1002/mrm.25555

Bolton HA; Zhu E; Terry AM; Guy TV; Koh WP; Tan SY; Power CA; Bertolino P; Lahl K; Sparwasser T; Shklovskaya E; Barbara BF, 2015, 'Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease', Journal of Clinical Investigation, 125, pp. 3627 - 3641, http://dx.doi.org/10.1172/JCI76031

Bourne R; Power C; Chatterjee A; Cowin G; Kurniawan N; Watson G, 2014, 'DISTINCTIVE WATER DIFFUSION PROPERTIES OF EPITHELIA MAY BE THE KEY TO BETTER CANCER IMAGING TECHNIQUES', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thibaudeau L; Taubenberger AV; Holzapfel BM; Quent VM; Fuehrmann T; Hesami P; Brown TD; Dalton PD; Power CA; Hollier BG; Hutmacher DW, 2014, 'A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone', DMM Disease Models and Mechanisms, 7, pp. 299 - 309, http://dx.doi.org/10.1242/dmm.014076

Tse BWC; Jovanovic L; Nelson CC; De Souza P; Power CA; Russell PJ, 2014, 'From Bench to Bedside: Immunotherapy for Prostate Cancer', BioMed Research International, 2014, http://dx.doi.org/10.1155/2014/981434

Xiao W; Graham PH; Hao J; Chang L; Ni J; Power CA; Dong Q; Kearsley JH; Li Y, 2013, 'Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0074253

Holzapfel BM; Thibaudeau L; Power C; Clements J; Russell ; Hutmacher DW, 2013, 'Humanised xenograft models of bone metastasis revisited: Novel insights into species-specific mechanisms of cancer cell osteotropism', Cancer and Metastasis Reviews, 32, pp. 129 - 145, http://dx.doi.org/10.1007/s10555-013-9437-5

Ritchie HE; Ababneh DE; Oakes DJ; Power C; Webster WS, 2013, 'The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo', Birth Defects Research Part B - Developmental and Reproductive Toxicology, 98, pp. 144 - 153, http://dx.doi.org/10.1002/bdrb.21050

Xiao W; Graham PH; Power C; Hao J; Kearsley J; Li Y, 2012, 'CD44 is a biomarker associated with human prostate cancer radiation sensitivity', Clinical and Experimental Metastasis, 29, pp. 1 - 9, http://dx.doi.org/10.1007/s10585-011-9423-7

Hao J; Madigan MC; Khatri A; Power C; Hung TT; Beretov J; Chang L; Xiao W; Cozzi PJ; Graham PH; Kearsley J; Li Y, 2012, 'In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147', PLoS One, 7, pp. 1 - 14, http://dx.doi.org/10.1371/journal.pone.0040716

Funnell AP; Norton LJ; Mak KS; Burdach J; Artuz CM; Twine NA; Wilkins MR; Power C; Hung TT; Perdomo JS; Bell-Anderson K; Orkin SH; Pearson RC; Crossley M, 2012, 'The CACCC-binding protein KLF3/BKLF represses a subset of KLF1/EKLF target genes and is required for proper erythroid maturation in vivo', Molecular and Cellular Biology, 32, pp. 3281 - 3292, http://dx.doi.org/10.1128/MCB.00173-12

Tse BW; Russell ; Lochner ; Forster ; Power C, 2011, 'IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms', PLoS One, 6, pp. e24241, http://dx.doi.org/10.1371/journal.pone.0024241

Wang L; Chen H; Liu F; Madigan MC; Power C; Hao J; Patterson K; Pourgholami MH; O Brien P; Perkins A; Li Y, 2011, 'Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer', Cancer Letters, 300, pp. 122 - 133, http://dx.doi.org/10.1016/j.canlet.2010.09.013

Hung TT; Chan J; Russell PJ; Power C, 2011, 'Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model', PLoS One, 6, pp. 1 - 8, http://dx.doi.org/10.1371/journal.pone.0019389

Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y, 2010, 'CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer', Current Cancer Drug Targets, 10, pp. 287 - 306

Power C; Marfleet T; Qualtiere L; Xiao W; Bretscher P, 2010, 'Development of Th1 Imprints to rBCG Expressing a Foreign Protein: Implications for Vaccination against HIV-1 and Diverse Influenza Strains', Journal of Biomedicine and Biotechnology, 2010, pp. 1 - 6, http://dx.doi.org/10.1155/2010/591348

Kiros T; Power C; Wei G; Bretscher P, 2010, 'Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge', Immunotherapy, 2, pp. 25 - 35

Power C; Pwint H; Cho J; Yu Y; Walsh W; Russell PJ, 2009, 'A novel model of bone-metastatic prostate cancer in immunocompetent mice', Prostate, 69, pp. 1613 - 1623

Li Y; Song YE; Rizvi SM; Power C; Beretov J; Raja C; Cozzi PJ; Morgenstern A; Apostolidis C; Allen BJ; Russell PJ, 2009, 'Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By (213)Bilabeled Multiple Targeted alpha Radioimmunoconjugates', Clinical Cancer Research, 15, pp. 865 - 875, http://dx.doi.org/10.1158/1078-0432.CCR-08-1203

Wang J; Rizvi SM; Madigan MC; Cozzi PJ; Power C; Qu CF; Morgenstern A; Apostolidis C; Russell PJ; Allen BJ; Li Y, 2006, 'Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.', Prostate, 66, pp. 1753 - 1767

Power C, 2000, 'Factors that influence T helper cell response to infection', Current Opinion in Infectious Diseases, 13, pp. 209 - 213

Back to profile page